MY APPROACH to the Athlete With Wolff-Parkinson-White Syndrome (WPW)

Trends Cardiovasc Med. 2018 Feb;28(2):154-155. doi: 10.1016/j.tcm.2017.09.005. Epub 2017 Oct 3.

Authors

Aaron L Baggish¹, Ankit B Shah²

Affiliations

¹ Massachusetts General Hospital, Harvard Medical School, Yawkey 5B, 55 Fruit St Massachusetts General, Boston, MA 02114. Electronic address: ABAGGISH@mgh.harvard.educooco.
² Massachusetts General Hospital, Harvard Medical School, Yawkey 5B, 55 Fruit St Massachusetts General, Boston, MA 02114.

PMID: 29032933
DOI: 10.1016/j.tcm.2017.09.005

No abstract available

MeSH terms

Action Potentials
Anti-Arrhythmia Agents / therapeutic use
Athletes*
Catheter Ablation*
Diagnosis, Differential
Electrocardiography
Exercise Test
Heart Conduction System / drug effects
Heart Conduction System / physiopathology
Heart Conduction System / surgery*
Heart Rate* / drug effects
Humans
Physical Endurance*
Predictive Value of Tests
Time Factors
Ventricular Premature Complexes / diagnosis
Ventricular Premature Complexes / etiology
Ventricular Premature Complexes / physiopathology
Ventricular Premature Complexes / surgery*
Wolff-Parkinson-White Syndrome / diagnosis
Wolff-Parkinson-White Syndrome / etiology
Wolff-Parkinson-White Syndrome / physiopathology
Wolff-Parkinson-White Syndrome / surgery*

Substances

Anti-Arrhythmia Agents